AmeriCares Honors Johnson & Johnson with power of partnership award
AmeriCares has awarded its annual Power of Partnership Award to the Johnson & Johnson Family of Companies for its longstanding support of AmeriCares emergency response work and ongoing medical assistance programs around the world. AmeriCares President & CEO Curt Welling presented the award today at the Healthcare Distribution Management Association's (HDMA) Business & Leadership Conference in Orlando, Fla. The Power of Partnership Award was created by AmeriCares and HDMA to recognize medical manufacturing and distribution organizations that have shown exceptional dedication to expanding access to medicines and health care for disadvantaged populations. 'It is because of great corporate partners like Johnson & Johnson that AmeriCares is able to deliver medical assistance to more than 90 countries annually,' Welling said. 'By placing Johnson & Johnson products in the hands of skilled medical professionals in the developing world, together we're restoring health and saving lives.' For over 25 years, Johnson & Johnson has supported AmeriCares humanitarian aid programs with product donations as well as cash grants. To date, Johnson & Johnson affiliates have donated more than $136 million worth of medicines and medical supplies to AmeriCares for people recovering from devastating natural disasters, facing civil conflict and suffering from extreme poverty. 'It's an honor to accept this award from AmeriCares, an organization whose founder, Bob Macauley, had a vision nearly 30 years ago of delivering medicines, medical supplies and aid to people in need around the world. The vision was exemplary, and the work today under the leadership of Curt Welling and his team is truly remarkable,' said Sharon D'Agostino, Vice President, Worldwide Corporate Contributions & Community Relations, Johnson & Johnson. 'Our partnership with AmeriCares is built on trust, common purpose and a commitment to helping people facing extremely challenging circumstances.' AmeriCares has delivered Johnson & Johnson products to people in need through its emergency response work, Medical Outreach Program and ongoing shipments to hospitals and clinics in the developing world. In recent years, Johnson & Johnson has extended its partnership with AmeriCares to include donations of LifeScan glucose meters and test strips and DePuy surgical instruments and orthopedic devices to health care facilities in parts of the world where access to these critical products is limited. The Johnson & Johnson Family of Companies also supports other innovative AmeriCares programs, including emergency preparedness training in El Salvador and a fistula surgery program in Tanzania, where products from the company's consumer, pharmaceutical and medical devices businesses are used. 'HDMA members and AmeriCares share the goal of delivering lifesaving medications to the people who need them every day,' said HDMA President and CEO John M. Gray. 'Through the support and leadership of HDMA member companies like Johnson & Johnson, the patients who need it most continue to have access to the right care at the right time. We are proud of our continuing partnership with AmeriCares.' About AmeriCares AmeriCares is a nonprofit global health and disaster relief organization which delivers medicines, medical supplies and aid to people in need around the world and across the United States. Since it was established in 1982, AmeriCares has distributed more than $9 billion in humanitarian aid to 147 countries. For more information, log onto www.AmeriCares.org. About Johnson & Johnson Caring for the world, one person at a time…inspires and unites the people of Johnson & Johnson. We embrace research and science - bringing innovative ideas, products and services to advance the health and well-being of people. Our approximately 114,000 employees at more than 250 Johnson & Johnson companies work with partners in health care to touch the lives of over a billion people every day, throughout the world. Through our philanthropy, Johnson & Johnson focuses on making life-changing, long-term differences in human health by targeting the world's major health-related issues. About HDMA HDMA is the national association representing primary healthcare distributors, the vital link in the healthcare system. Each business day, HDMA member companies ensure that more than nine million prescription medicines and healthcare products are safely delivered to more than 165,000 pharmacies, hospitals, nursing homes, physician offices, clinics and others nationwide. HDMA and its members work daily to provide value and contain costs, saving the nation's healthcare system an estimated $32 billion per year. For more information, visit www.HealthcareDistribution.org.
-
Most popular related searches
Related news
-
U.S. FDA approves Xarelto to treat venous thromboembolism (VTE) and to prevent VTE in children
Xarelto is the only Factor Xa anticoagulant FDA approved for pediatric patients and offers a flexible weight-based dosing Xarelto is available in both oral tablet and liquid suspension formulations for use in appropriate children less than 18 years of age Convenient liquid formulation advances standard of care for children; alleviates administration challenges found with injectable alternatives The U.S. Food and Drug Administration (FDA) has approved two pediatric indications for Xarelto (rivaroxaban): the...
-
Phase III trial with Nubeqa (darolutamide) in combination with docetaxel and androgen deprivation therapy meets primary endpoint of significantly increasing overall survival in patients with metastatic hormone-sensitive prostate cancer
ARASENS trial demonstrates an increase in overall survival evaluating darolutamide in combination with docetaxel and androgen deprivation therapy (ADT) compared to docetaxel and ADT, a standard of care in metastatic hormone-sensitive prostate cancer (mHSPC) / Bayer plans to present these pivotal data at a forthcoming scientific congress and to discuss them with health authorities / ARASENS is part of broad development program for darolutamide which includes another ongoing Phase III trial in mHSPC, ARANOTE,...
-
InspireMD Receives Reimbursement Approval for CGuard™ Embolic Prevention System from the French National Authority for Health
InspireMD, Inc. (Nasdaq: NSPR), a global developer of the CGuard™ Embolic Prevention Stent System (EPS) device for the treatment of Carotid Artery Disease (CAD) and stroke prevention, today announced that its CGuard EPS stent system has received a positive opinion from the National Commission for the Evaluation of Medical Devices and Health Technologies (CNEDIMTS) of the French National Authority for Health (HAS) regarding reimbursement in France, and the CGuard EPS is being added to the list of reimbursed...
-
IFEMA MADRID will host the Congress of the European Association for Cranio Maxillo Facial Surgery in the Palacio Municipal
This biennial congress comes to Madrid as the Spanish Professor Julio Acero occupies the Presidency of the Association, and it expects to host more than 2.000 attendees from 70 countries. This edition will mean the return to the face-to-face format after the last appointment of the Congress, celebrated in Munich in 2018, and the virtual edition celebrated last summer after the impossibility of holding it in person in Paris in 2020. IFEMA MADRID continues working for the reactivation of the MICE sector in...
-
Artugen Announces Five Abstracts Published in the 30th ECCMID Abstract Book
Clostridioides difficile infection (CDI) causes the most common healthcare-associated infections in the United States and the most frequent hospital-acquired intestinal infection in Europe and worldwide. The prevalence of C. difficile outbreaks since the early 2000s has resulted in higher morbidity and mortality along with increasing medical costs throughout the world. Without effective antibiotics and therapeutics for the prevention and treatment of infections, many of the achievements of modern medicine such...
Customer comments
No comments were found for AmeriCares Honors Johnson & Johnson with power of partnership award. Be the first to comment!